Unibest
← Back to patent-cliff list

CAS 110-16-7

maleic acid

Codes: AVAT-011, AFAT-018

Application context (from source-drug indications)

ThrombocytopeniaAvatrombopag MaleateImmune thrombocytopenic purpuraAvatrombopag MaleateLiver diseaseAvatrombopag MaleateNon-small cell lung cancerAfatinib DimaleateHead and neck squamous cell carcinomaAfatinib DimaleateHead and neck cancerAfatinib DimaleateChordomaAfatinib DimaleateSquamous cell carcinomaAfatinib DimaleateGallbladder cancerAfatinib Dimaleate

Source drugs (routes using this intermediate)

DrugTierExpiry
Avatrombopag MaleateTier C — Watch / trade2030
Afatinib DimaleateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API Works4-(4-chloro-2-thienyl)-2-ThiazolaMine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-amine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site1-Cyclohexylpiperazine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works5,6-Dichloronicotinic acid
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.